US Life Expectancy Rose The First Time Since COVID-19 Pandemic

Updated Dec 20, 2024 | 10:10 AM IST

SummaryThe average life expectancy from birth rose from 77.5 years in 2022 to 78.4 years in 2023 as per the figures released by the Centers for Disease Control and Prevention (CDC). The number of deaths recorded in 2023 stood at 3,090,964, which was 189,000 less than in 2022.
Life expectancy rates in US

Credits: Canva

For the first time ever since the COVID-19 pandemic. the United States has seen a rise in its life expectancy rates. The life expectancy rates in the United States continued to rebound in 2023 due to the decline it faced in pandemic-era, and had increased by a year from 2022.

The average life expectancy from birth rose from 77.5 years in 2022 to 78.4 years in 2023 as per the figures released by the Centers for Disease Control and Prevention (CDC). The number of deaths recorded in 2023 stood at 3,090,964, which was 189,000 less than in 2022. The rise in life expectancy also saw a hike by 6% drop in the overall mortality rate in the US population. Which, in numbers could be explained as 798.8 deaths per 100,000 people in 2022 to 750.5 per 100,000 in 2023.

The Trend of Life Expectancy in US from 1970 to 2023

If one must see the numbers in graph from 1970 to 2023, it seems like an upward trend, with a severe drop in 2020s, but again a rise in 2023. The average age between 1970 to 1975 remained between 70.8 years to 72.6, for the next five years, it remained till 73.7 years. A long line of increment on the graph, if one has to draw then peaked at 1992 at 75.8 years, but dropped at 75.5 in 1993, though, counted as a usual fluctuation. The graph, though grew stable, though with minor fluctuation till 2019 at 78.8 years and saw a severe decline in 2020 at 77 years, then again in 2021 at 76.4, its lowest level since 1996, which was at 76.1. The rise could be noted from 2022, when the vaccination was made available against the COVID-19 pandemic, and in 2022, the life expectancy age was at 77.5. A visible change is noted in 2023, as the age is recorded at 78.4.

ALSO READ: Countries With The Highest And Lowest Life Expectancy Rates

Impact of COVID-19 pandemic

The pandemic was a major contributor for country's declining life expectancy rates. It was the 3rd-leading cause of death in 2020, being responsible for more than 10% of all deaths. In 2021, though seen a slight hike, the virus still remained the 3rd leading cause of death, accounting for 12% of the total deaths. Finally, in 2022, the virus became the 4th leading cause of death.

What are the other reasons apart from COVID-19 for America's life expectancy deaths?

Heart Disease: 167.2 death rate per 100,000 in 2022, which went down to 162.1 in 2023

Cancer: 142.3 death rate per 100,000 in 2022, which went down to 141.8 in 2023

Unintentional Injuries: 64 death rate per 100,000 in 2022, which went down to 62.3 in 2023

Stroke: 39.5 death rate per 100,000 in 2022, which went down to 69 in 2023

Chronic Lower Respiratory Disease: 34.3 death rate per 100,000 in 2022, which went down to 33.4 in 2023

Alzheimer's Disease: 28.9 death rate per 100,000 in 2022, which went down to 27.7 in 2023

Diabetes: 24 death rate per 100,000 in 2022, which went down to 22.4 in 2023

Kidney Disease: 13.8 death rate per 100,000 in 2022, which went down to 13.1 in 2023

Chronic Liver Disease and Cirrhosis: 13.8 death rate per 100,000 in 2022, which went down to 13 in 2023

COVID-19: 44.5 death rate per 100,000 in 2022, which went down to 11.9 in 2023

End of Article

UK Health Chiefs Warn of Rising Cases of Deadly Chikungunya Virus That Can Cause Body to ‘Fold In on Itself’

Updated Aug 14, 2025 | 01:02 PM IST

SummaryUK health officials have reported record chikungunya cases and the first oropouche virus infections, both linked to overseas travel. Spread by mosquitoes and midges, these viruses cause severe symptoms, with prevention through repellents, protective clothing, and vaccination recommended for travellers.
Credits: Canva

Credits: Canva

Health authorities in the UK have reported a significant rise in chikungunya cases, a mosquito-borne disease known for causing severe joint pain that can leave sufferers hunched over. Between January and June 2025, there were 73 confirmed cases in England, Wales, and Northern Ireland, more than double the 27 recorded during the same period in 2024. The UK Health Security Agency (UKHSA) says this is the highest number ever recorded, with nearly all linked to overseas travel.

What is Chikungunya?

Spread by the bite of infected Aedes mosquitoes, particularly the Aedes aegypti and Aedes albopictus species, chikungunya is not usually deadly but can be devastating for the very young, the elderly, or those with underlying health conditions.

Typical symptoms include:

  • Excruciating joint pain that can leave sufferers bent over in agony
  • High fever and headaches
  • Muscle aches and swelling in the joints (especially hands and feet)
  • Nausea, fatigue, and a rash that’s red, bumpy, and decidedly not Instagrammable

In severe cases, the arthritis-like pain can linger for months or even years, turning every movement into a reminder that mosquitoes are not just a mild holiday nuisance.

The majority of UK cases this year were linked to travel to Sri Lanka, India, and Mauritius. All were reported in England, with London taking the dubious honour of having the most cases. However, the two mosquito species that spread the virus are not established in the UK, so there is no risk of it transmitting locally.

UK logs first cases of oropouche virus

As if one virus was not enough, the UK has also logged its first cases of the oropouche virus, also dubbed ‘sloth fever’. This one circulates in the wild between primates, sloths, and birds before occasionally hopping over to humans via midges or mosquitoes.

Found primarily in the Amazon basin, oropouche has recently started wandering further across the Americas. All the UK cases were linked to travel from Brazil, so unless your staycation involves tree-dwelling mammals and tropical insects, you are safe for now.

The Global Bug Crawl

Chikungunya is typically found in Africa and southern Asia, but 2025 has seen it pop up in unexpected places. Outbreaks have been reported in China, the Indian Ocean islands of Reunion, Mayotte and Mauritius, and across the Americas. In southern China, more than 7,000 people have been infected since June, prompting COVID-style lockdowns in Foshan and at least a dozen other cities in Guangdong province. Hong Kong and Taiwan have also reported cases.

Health officials are urging travellers to take bite prevention seriously.

How to safeguard against mosquito bites

According to the US Centres for Disease Control and Prevention (CDC), your best defence is to stop mosquitoes from making contact in the first place.

Top tips include:

  • Use Environmental Protection Agency (EPA)-registered insect repellent
  • Wear long-sleeved shirts and trousers (mosquitoes can’t bite what they can’t reach)
  • Treat clothing and gear with 0.5% permethrin for extra armour
  • Choose accommodation with air conditioning or window screens
  • If sleeping outdoors, use a mosquito net unless you enjoy sharing your bed with the local insect population

Vaccination

In addition to covering up and dousing yourself in repellent, some travellers may be advised to get the chikungunya vaccine before heading to certain destinations. Your healthcare provider can help you decide if this applies to your travel plans.

Why the Surge Now?

Several factors could be behind the sharp rise in cases. Increased international travel post-pandemic, changing weather patterns favouring mosquito breeding, and outbreaks in popular holiday destinations have created a perfect storm. Mosquitoes thrive in warm, wet conditions, and with climate change extending those conditions into more regions, these viruses are no longer staying politely within their old borders.

Chikungunya virus can turn a dream getaway into a painful endurance test, and once contracted, it is all about managing symptoms; there is no cure. The same goes for oropouche: prevention is your best friend. In the world of tropical diseases, an ounce of repellent really is worth a pound of cure.

End of Article

Scott Swift, Taylor Swift's Dad Underwent A Quintuple Bypass Heart Surgery, Here's What We Know About It So Far

Updated Aug 14, 2025 | 09:16 AM IST

SummaryTaylor Swift revealed that her father, Scott Swift, 73, recently had a quintuple bypass after five blockages were found during a resting stress test. Calling the surgery “intense,” she moved in to care for him. He’s recovering well, while her mother, Andrea, also recently underwent knee replacement surgery. Read on to know more.
Scott Swift, Pop Singer Taylor Swift's Dad Underwent A Quintuple Bypass Heart Surgery After A Stress Test, Here's What We Know About It So Far

Credits: Treemily

Scott Swift, 73, pop singer Taylor Swift's dad just underwent a quintuple bypass surgery, revealed Taylor during one of the episodes of Travis Kelce and Jason Kelce's New Heights podcast.

She also shared that she had moved in with her dad earlier this year to take care of him for a speedy recovery. She noted that her father has been full of gratitude after the surgery. "He was the loveliest patient ever. He just kept saying thank you over and over again."

Why Did Scott Swift Need A Surgery?

Taylor called the surgery "really intense" and said that her dad's heart always had a healthy ECG or electrocardiogram. He also ensures to get it every year to remain a step ahead of any physical ailments. However, five hard blockages were found in his heart during a resting stress test.

"He's been telling all his friends, 'You need to get the stress test,' because that's what's actually preventative. If you can find that earlier, you don't have to have a bypass surgery," she said.

Taylor confirmed that her father is doing "incredibly well" and that his humor has helped him go through during the hard times. It still is very much intact in him.

She shares that he did not know how many blockages he's had, on being told that he underwent a quintuple bypass, which means five blockages, he also joked about it. "Well, you see, I come from a very competitive family," he told Taylor.

What Is A Stress Test?

Scott Swift, Taylor Swift's dad recommends everyone to take stress test

As per the National Institute of Health (NIH), US, it is a form of physical test that typically utilizes electrocardiography along with blood pressure monitoring and exercise, which involves a treadmill or bicycle.

However, in a resting stress test, the assessment happens when the heart muscle is at rest after stress. This stress helps in identifying areas of reduced blood flow like ischemia or damage to the heart muscle, which can indicate conditions like coronary artery disease.

The test involves injecting a radioactive tracer into the bloodstream, then using a special camera to take images of the heart at rest and after stress.

What Is A Bypass Surgery?

Scott Swift, Taylor Swift's dad undergoes quintuple bypass surgery

As per Johns Hopkins Medicine, bypass surgery or coronary artery bypass graft surgery (CABG) is a procedure used to treat coronary artery disease. Coronary artery disease (CAD) is the narrowing of the coronary arteries. These are the blood vessels that supply oxygen and nutrients to the heart muscle. CAD is caused by a build-up of fatty material within the walls of the arteries. This buildup narrows the inside of the arteries, limiting the supply of oxygen-rich blood to the heart muscle.

How Does It Work?

One way to treat the blocked or narrowed arteries is to bypass the blocked portion of the coronary artery with a piece of a healthy blood vessel from elsewhere in your body. Blood vessels, or grafts, used for the bypass procedure may be pieces of a vein from your leg or an artery in your chest. An artery from your wrist may also be used.

ALSO READ: 4 Rare Heart Diseases That Are Becoming Common By Each Passing Day

This surgery is done to treat a blockage or narrowing of one or more of the coronary arteries. It can restore the blood supply to your heart muscle when nonsurgical procedures are not a choice.

More Updates From The Swift Family

In addition to Scott, Taylor shared that her mom Andrea Swift, too, under a procedure. “My mom just got a new knee,” Taylor shared. “She’s doing great. She’s scampering around. We’re not quite at scampering yet, but she’s doing great.”

She noted that her parents are her best friends.

"It was actually one of the most special things that's ever happened to me, spending all that time with them this summer. You have those long talks that you don't have when it's a small, concentrated period of time.”

End of Article

FDA Confirms Resolution of Nationwide IV Saline Shortage

Updated Aug 14, 2025 | 06:41 AM IST

SummaryThe FDA has declared the nationwide shortage of sodium chloride 0.9% IV saline over, crediting joint efforts with federal and industry partners. Supply is restored, but the agency will continue monitoring and addressing other IV fluid shortages.
FDA Confirms Resolution of Nationwide IV Saline Shortage

Credits: Canva

The U.S. Food and Drug Administration (FDA) has announced that the nationwide shortage of sodium chloride 0.9 percent intravenous (IV) saline solution, which is a critical medical supply used in hospitals and emergency care, has officially come to an end. The resolution marks a significant milestone in stabilizing the supply of one of the most essential tools in patient care.

Collaborative Effort to Restore Supply

FDA Commissioner Marty Makary, M.D., M.P.H., credited the resolution of the shortage to a coordinated effort between the FDA, the Administration for Strategic Preparedness and Response (ASPR), and industry partners. According to Makary, this multi-agency and cross-sector collaboration allowed for rapid action to address the supply gap that had strained healthcare facilities across the country.

To overcome the shortage, the FDA and its partners implemented several urgent measures. These included enabling the temporary import of IV saline solutions from approved international sources, expediting the review process for domestic manufacturing expansions, and extending expiry dates for existing products after rigorous safety assessments. This combination of strategies helped boost production capacity and prevent supply chain bottlenecks.

Impact on Hospitals and Patient Care

Sodium chloride 0.9 percent IV saline is used for hydration, administering medications, and treating dehydration and other critical conditions. The shortage, which had persisted for months, forced hospitals to ration supplies and find alternative solutions. Medical professionals often had to adjust treatment protocols or use smaller IV bags to stretch resources, a situation that placed additional strain on already burdened healthcare systems.

Now, with supplies back to normal levels, the FDA has confirmed that the product will be removed from its official Drug Shortage Database. Facilities are being advised to return to using FDA-approved products whenever available.

ALSO READ: The Truth About IV Drips: Are They Better Than Food Or Supplements?

Ongoing Efforts to Prevent Future Shortages

While celebrating the resolution, the FDA emphasized that its work to secure medical product availability is far from over. Makary stressed that the agency remains committed to addressing other ongoing shortages, including those affecting certain IV fluids.

“The FDA remains focused on doing all we can to help mitigate shortages and prevent them from occurring,” Makary said in a statement. “We will continue working diligently to monitor supply levels, anticipate potential disruptions, and support a robust, secure, and transparent supply chain for medical products.”

The agency’s strategy involves close monitoring of manufacturer reports, collaboration with other federal agencies, and engagement with the private sector to anticipate challenges before they escalate into full-scale shortages.

A Model for Crisis Response

Experts say the resolution of the saline shortage could serve as a model for responding to future disruptions in medical supply chains. By acting quickly, coordinating with multiple stakeholders, and making temporary regulatory adjustments, the FDA and its partners were able to restore availability without compromising patient safety.

Public health advocates note that the success also underscores the importance of maintaining diverse manufacturing sources, both domestically and internationally, to safeguard against sudden disruptions caused by disasters, supply chain issues, or unexpected surges in demand.

The FDA’s announcement brings relief to healthcare providers nationwide, who have been navigating supply constraints for essential items over the past few years. With IV saline now in stable supply, hospitals can focus more on patient care without the added stress of product scarcity.

However, the agency cautions that vigilance is essential. The FDA will continue to work with manufacturers, monitor production levels, and apply lessons learned from this shortage to strengthen the overall resilience of the nation’s medical supply system.

End of Article